27461472|t|Activation of ephrinB-EphB receptor signalling in rat spinal cord contributes to maintenance of diabetic neuropathic pain
27461472|a|Diabetic neuropathic pain (DNP) is severe and intractable in clinic. The specific cellular and molecular mechanisms underlying DNP remain elusive and its treatment are limited. We investigated roles of EphB1 receptor in the development of DNP. Diabetic neuropathic pain was produced in male, adult, Sprague-Dawley rats by a single i.p. streptozotocin (STZ) or alloxan. Western blot analysis and immunohistochemistry were used to analyse expression of EphB1 receptor as well as the activation of the glial cells and the pro-inflammatory cytokines in the spinal cord. DNP manifested as mechanical allodynia, which was determined by measuring incidence of foot withdrawal in response to mechanical indentation of the hind paw by an electro von Frey filament. Diabetic neuropathic pain and high blood glucose were exhibited simultaneously in around 70% of animals that received i.p. STZ or alloxan. Phosphorylation of EphB1, activation of the astrocytes and microglial cells, and level of tumour necrosis factor (TNF)-α and interleukin (IL)-1β in the spinal cord were significantly increased in rats with DNP. Spinal blocking EphB1 receptor activation in the late phase after STZ injection significantly suppressed the established mechanical allodynia as well as activation of the astrocytes and microglial cells and activity of TNF-α and IL-1β. However, spinal treatment of EphB1 - Fc in the early phase after STZ injection did not prevent the induction of DNP. EphB1 receptor activation in the spinal cord is critical to the maintenance, but not induction of diabetic pain. EphB1 receptor may be a potential target for relieving the established diabetic pain. Activation of EphB1 receptor in the spinal cord is critical to maintaining the established diabetic neuropathic pain, but not to diabetic pain induction. Spinal blocking EphB1 receptor activation suppresses ongoing diabetic neuropathic pain.
27461472	50	65	rat spinal cord	T017	UMLS:C1882864
27461472	96	104	diabetic	T033	UMLS:C0241863
27461472	105	121	neuropathic pain	T033	UMLS:C3714625
27461472	122	130	Diabetic	T033	UMLS:C0241863
27461472	131	147	neuropathic pain	T033	UMLS:C3714625
27461472	149	152	DNP	T033	UMLS:C3714625
27461472	183	189	clinic	T092	UMLS:C0442592
27461472	204	212	cellular	T038	UMLS:C0007613
27461472	217	226	molecular	T038	UMLS:C1148560
27461472	249	252	DNP	T033	UMLS:C3714625
27461472	324	338	EphB1 receptor	T103	UMLS:C0907648
27461472	361	364	DNP	T033	UMLS:C3714625
27461472	366	374	Diabetic	T033	UMLS:C0241863
27461472	375	391	neuropathic pain	T033	UMLS:C3714625
27461472	421	440	Sprague-Dawley rats	T204	UMLS:C0034715
27461472	458	472	streptozotocin	T103	UMLS:C0038432
27461472	474	477	STZ	T103	UMLS:C0038432
27461472	482	489	alloxan	T103	UMLS:C0002151
27461472	491	512	Western blot analysis	T058	UMLS:C0949466
27461472	517	537	immunohistochemistry	T058	UMLS:C0021044
27461472	559	569	expression	T038	UMLS:C1171362
27461472	573	587	EphB1 receptor	T103	UMLS:C0907648
27461472	621	632	glial cells	T017	UMLS:C0027836
27461472	641	667	pro-inflammatory cytokines	T103	UMLS:C0079189
27461472	675	686	spinal cord	T017	UMLS:C0037925
27461472	688	691	DNP	T033	UMLS:C3714625
27461472	706	726	mechanical allodynia	T033	UMLS:C2936719
27461472	775	779	foot	T017	UMLS:C0016504
27461472	806	828	mechanical indentation	T082	UMLS:C0332467
27461472	836	840	hind	T082	UMLS:C2983612
27461472	841	844	paw	T017	UMLS:C0687080
27461472	878	886	Diabetic	T033	UMLS:C0241863
27461472	887	903	neuropathic pain	T033	UMLS:C3714625
27461472	908	926	high blood glucose	T033	UMLS:C2919432
27461472	974	981	animals	T204	UMLS:C0003062
27461472	1001	1004	STZ	T103	UMLS:C0038432
27461472	1008	1015	alloxan	T103	UMLS:C0002151
27461472	1017	1032	Phosphorylation	T038	UMLS:C0031715
27461472	1036	1041	EphB1	T103	UMLS:C0907648
27461472	1061	1071	astrocytes	T017	UMLS:C0004112
27461472	1076	1092	microglial cells	T017	UMLS:C0206116
27461472	1107	1129	tumour necrosis factor	T103	UMLS:C1456820
27461472	1130	1137	(TNF)-α	T103	UMLS:C1456820
27461472	1142	1161	interleukin (IL)-1β	T103	UMLS:C0021753
27461472	1169	1180	spinal cord	T017	UMLS:C0037925
27461472	1213	1217	rats	T204	UMLS:C0034721
27461472	1223	1226	DNP	T033	UMLS:C3714625
27461472	1228	1234	Spinal	T082	UMLS:C0521329
27461472	1244	1258	EphB1 receptor	T103	UMLS:C0907648
27461472	1294	1297	STZ	T103	UMLS:C0038432
27461472	1298	1307	injection	T058	UMLS:C1533685
27461472	1349	1369	mechanical allodynia	T033	UMLS:C2936719
27461472	1399	1409	astrocytes	T017	UMLS:C0004112
27461472	1414	1430	microglial cells	T017	UMLS:C0206116
27461472	1447	1452	TNF-α	T103	UMLS:C1456820
27461472	1457	1462	IL-1β	T103	UMLS:C0021753
27461472	1473	1479	spinal	T082	UMLS:C0521329
27461472	1493	1498	EphB1	T103	UMLS:C0907648
27461472	1501	1503	Fc	T103	UMLS:C0034805
27461472	1529	1532	STZ	T103	UMLS:C0038432
27461472	1533	1542	injection	T058	UMLS:C1533685
27461472	1576	1579	DNP	T033	UMLS:C3714625
27461472	1581	1595	EphB1 receptor	T103	UMLS:C0907648
27461472	1614	1625	spinal cord	T017	UMLS:C0037925
27461472	1679	1687	diabetic	T033	UMLS:C0241863
27461472	1688	1692	pain	T033	UMLS:C0030193
27461472	1694	1708	EphB1 receptor	T103	UMLS:C0907648
27461472	1739	1748	relieving	T058	UMLS:C0002766
27461472	1765	1773	diabetic	T033	UMLS:C0241863
27461472	1774	1778	pain	T033	UMLS:C0030193
27461472	1794	1808	EphB1 receptor	T103	UMLS:C0907648
27461472	1816	1827	spinal cord	T017	UMLS:C0037925
27461472	1871	1879	diabetic	T033	UMLS:C0241863
27461472	1880	1896	neuropathic pain	T033	UMLS:C3714625
27461472	1909	1917	diabetic	T033	UMLS:C0241863
27461472	1918	1922	pain	T033	UMLS:C0030193
27461472	1934	1940	Spinal	T082	UMLS:C0521329
27461472	1950	1964	EphB1 receptor	T103	UMLS:C0907648
27461472	1995	2003	diabetic	T033	UMLS:C0241863
27461472	2004	2020	neuropathic pain	T033	UMLS:C3714625